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Key Points
• Specific phosphoryla-
tion events are associ-
ated with RBC
deformation.
• Inhibition of GSK3
and Lyn impairs RBC
capacity to undergo
successive deformation
and resist shear stress.
The capacity to undergo substantial deformation is a deﬁning characteristic of the red blood
cell (RBC), facilitating transit through the splenic interendothelial slits andmicrovasculature.
Establishmentof this remarkablepropertyoccursduringaprocessof reticulocytematuration
that begins with egress through micron-wide pores in the bone marrow and is completed
within the circulation. The requirement to undertake repeated cycles of deformation
necessitates that both reticulocytes and erythrocytes regulate membrane-cytoskeletal
protein interactions in order to maintain cellular stability. In the absence of transcriptional
activity, modulation of these interactions in RBCs is likely to be achieved primarily through
speciﬁc protein posttranslational modiﬁcations, which at present remain undeﬁned. In this
study, we use high-throughput methods to deﬁne the processes that underlie the response to
deformation and shear stress in both reticulocytes and erythrocytes. Through combination
of a bead-basedmicrosphiltration assay with phosphoproteomics we describe posttranslational
modiﬁcation of RBC proteins associated with deformation. Using microsphiltration and
microﬂuidic biochip-based assays, we explore the effect of inhibiting kinases identiﬁed using
this dataset. We demonstrate roles for GSK3 and Lyn in capillary transit and maintenance of
membrane stability following deformation and show that combined inhibition of these kinases
signiﬁcantly decreases reticulocyte capacity to undergo repeated deformation. Finally, we
derive a comprehensive and integrative phosphoproteomic dataset that provides a valuable
resource for further mechanistic dissection of the molecular pathways that underlie the RBC’s
response to mechanical stimuli and for the study of reticulocyte maturation.
Introduction
The capacity to undergo substantial deformation is a defining characteristic of the red blood cell (RBC).
Establishment of this remarkable property occurs during a process of reticulocyte maturation that begins
in the bone marrow and is completed within the circulation in which the nascent reticulocyte, having
expelled its nucleus, remodels its membrane to acquire the recognizable biconcave morphology of the
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mature erythrocyte. While the deformability of early reticulocytes
is known to be lower than that of erythrocytes1-3 but increase
progressively throughout the maturation process, reticulocytes
themselves must undergo extreme deformations without damage
or lysis. These include bone marrow egress (before entering
peripheral circulation) as well as multiple traversals of the splenic
interendothelial slits (during circulatory maturation) and the micro-
vasculature. As a result, reticulocytes are necessarily exposed to
high pressures and shear stress, which in turn may partially drive the
processes underlying maturation.
Modulation of reticulocyte and erythrocyte properties through
response to shear stress is a well described phenomenon. Shear
stress has been reported to be implicated in the regulation of
adenosine triphosphate (ATP) release by erythrocytes,4,5 removal of
autophagic vesicles from circulating reticulocytes,6 and general
induction of autophagy in other mammalian cells.7 In erythrocytes,
shear stress is known to induce calcium ion entry through activation
of the mechanically activated cation channel Piezo1,8 regulating the
volume changes necessary for the maintenance of homeostasis during
deformation.9 Increases in intracellular calcium are known to promote
phosphorylation of multiple proteins through interaction with sensors
such as calmodulins and C2 domain-containing proteins.10-13 Phos-
phorylation, in turn, regulates cytoskeletal alterations and interactions14,15
as well as the stability of the erythrocyte membrane.10,16
Understanding the biochemical mechanisms that enable or are
activated upon RBC deformation is an extremely difficult proposition
given the challenges associated with isolating cells undertaking this
process. Various types of shear stress/deformation-inducing systems
exist specifically for the study of RBC properties,17-19 but most of the
focus of the use of those systems has been on the assessment of the
mechanical and physical properties of the cells or the high-throughput
screening of chemical compound effects on these characteristics20
rather than elucidation of the molecular basis of RBC deformation.
In this study, we aim to better define the phosphorylation events
that underlie the response to deformation and shear stress in
both reticulocytes and erythrocytes. Using in vitro systems that
mimic deformation through the spleen and microvasculature,
respectively, we have captured cells in states immediately pre-,
mid-, and postdeformation and used phosphoproteomics to obtain
a unique and comprehensive shear-response dataset, providing
a valuable resource for further studies of the processes involved in
RBC deformation and reticulocyte maturation. We then validate the
importance of 2 of these modifications in the cellular response to
shear stress through chemical inhibition of the respective proteins.
Methods
Erythrocyte isolation and in vitro erythroid culture
Erythrocytes were isolated by leukofiltration from the RBC fraction
obtained by Histopaque separation of healthy donor platelet apher-
esis waste blood. In vitro–cultured reticulocytes were differentiated
from CD341 cells isolated from the mononuclear cell fraction
according to previously published protocols.21 All source material
was provided with written informed consent for research use given
in accordance with the Declaration of Helsinki (National Health
Service Blood and Transplant, Filton, Bristol, United Kingdom). The
research into the mechanisms of erythropoiesis was reviewed and
approved by the Bristol Research Ethics committee (REC Number
12/SW/0199).
Proteomics experimental design, data acquisition
and analysis
Two experiments were performed: (1) A comparison of erythrocytes
and in vitro–derived reticulocytes lysed before, during, and after
shear stress exposure through microsphere filtration (microsphiltra-
tion) was performed, with at least 3 biological repeats per cell type
and shear stress exposure condition, generating a total of 21
individual samples that were processed through qualitative titanium
dioxide–enriched phosphoproteomics; and (2) a comparison of
reticulocytes lysed before and after shear stress exposure through
passage in successive microfluidic constrictions with 3 biological
repeats and generating a total of 6 individual samples.
Each sample corresponds to 10 3 106 cells. The protein content
between samples was equalized through hemoglobin estimation via
the use of Drabkin’s reagent, using different standard curves for
reticulocytes and erythrocytes due to their differences in average
hemoglobin concentration. Data are available via ProteomeXchange
with identifiers PXD013652 and PXD013960, with corresponding
DOIs 10.6019/PXD013652 and 10.6019/PXD013960. Further
information and reasoning for the chosen proteomics design may
be found in the supplemental Rationale material. Extended methods
for sample preparation, data acquisition and analysis are provided
in the supplemental Methods.
ARCA sample preparation and analysis
A total of 2 3 106 cells were diluted in 200 mL of a polyvinylpyrro-
lidone solution (viscosity, 28.1 mPa×s; Mechatronics Instruments).
Samples were assessed in an Automated Rheoscope and Cell
Analyzer (ARCA)22 according to previously published protocols.23
At least 1500 valid cells per sample were analyzed using bespoke
ARCA analysis software.
Microsphiltration
A microsphiltration device was built as originally described by
Deplaine et al.24 A 1:1 mixture of 15 to 25 mm and 5 to 15 mm
diameter metal microspheres (1 g; 1 g consisting of 96.50% tin,
3.00% silver, and 0.50% copper; Industrie des Poudres Sphe´ri-
ques) was resuspended in 5 mL PBSAG (phosphate-buffered
saline 1 1 mg/mL bovine serum albumin 1 2 mg/mL glucose). A
total of 600 mL of the microsphere suspension were loaded directly
on top of the antiaerosol filter of the inverted pipette tip. The
remaining volume was filled with PBSAG. A 50-mL syringe was
loaded with PBSAG and connected to a 3-way stopcock, which
was connected to the pipette tip using silicone tubing (Cole-
Parmer). A 1-mL syringe was used for loading the cell suspension
into the microsphiltration system through the stopcock. Pressure
was created manually through slow and constant depression of the
50-mL syringe plunger.
For the proteomics experiment, cells were lysed at 3 points: (1)
before use of the microsphiltration system, (2) during the point of
maximum cell density in the bead layer, and (3) postrecovery of the
cells from the microsphiltration system. For recovery during the
point of maximum cell density in the bead layer, pressure was
stopped immediately, and the top of the pipette filter tip was cut
open. Then, the PBSAG present in the system was aspirated. Forty
microliters of lysis buffer were carefully added to the bead layer and
incubated for 10 minutes at 4°C. The bead layer and lysate were
collected into a microcentrifuge tube and centrifuged for 10minutes
2654 MOURA et al 10 SEPTEMBER 2019 x VOLUME 3, NUMBER 17
.For personal use only on October 2, 2019. at University of Bristol Library www.bloodadvances.orgFrom 
at 16100g, 4°C. The supernatant was then collected. For recovery
after the microsphiltration system, the resulting suspension was
centrifuged for 5 minutes at 400g, 4°C, and the cells were counted
and lysed. Lysates were then equalized in regard to cell number
through quantitation of hemoglobin using Drabkin’s reagent.
For the percentage of cell recovery experiment, cells were treated
overnight with 1:1000 dimethyl sulfoxide (DMSO) as a control, or
a pharmacological inhibitor (3 mM bafetinib [specific Lyn inhibitor,
50% inhibition concentration (IC50): 19 nM; Insight Biotechnology],
10 nM CHIR-98014 [specific GSK3 inhibitor, GSK3a IC50: 0.65
nM, GSK3b IC50: 0.58 nM, closest homolog Cdc2 IC50: 3.7 mM;
Stratech Scientific], or a combination of both). Following treat-
ment, the cells were stained with CellTracker Green CMFDA Dye
(Invitrogen) for 45minutes at 37°C. After staining, the cells were mixed
with untreated, unstained cells in a 5:95 mixture and resuspended in
PBSAG. The resulting cell suspension was subjected to micro-
sphiltration and analyzed through flow cytometry.
For fixation of cells in the bead layer, the filter tip was cut and the
PBSAG aspirated as described earlier. A total of 100 mL of fixing
solution (1% paraformaldehyde and 0.0075% glutaraldehyde [v/v]
in PBSAG) were carefully added to the bead layer and incubated for
10 minutes at room temperature. One milliliter of PBSAG was
added for resuspension of the bead layer and the suspension was
collected into microcentrifuge tubes. The beads were let to
sediment by gravity and, 5 minutes later, the supernatant containing
the fixed cells was collected into new microcentrifuge tubes. The
cell suspension was centrifuged, and the cells were washed twice
in PBSAG to remove any remaining microbeads. The fixed cells
were then stored at 4°C.
Microfluidic multiconstriction assay
The microfluidic biochip was designed and fabricated as described
by Lizarralde Iragorri et al.19 An MFCS-EZ microfluidic flow control
system (Fluigent) was used to regulate the flow pressure in the
microfluidic biochip. The biochip was connected to the pump by
1.6-mm silicone tubing and male Luer connectors and mounted on
the stage of an inverted AxioObserver Z1 microscope (Zeiss)
coupled with a Phantom Miro M 320S high-speed camera, with
imaging at 3100 magnification.
For each assay, 60 mL of reticulocyte or erythrocyte suspensions at
2.5% hematocrit were loaded in the input well of the biochip and
perfused at constant pressure (150 mBar). The 2.5% hematocrit,
lower than the literature value of 30%, was used to allow for the
identification of individual cells in the acquired images. For inhibitor
treatment, the cells were treated with 1:1000 DMSO as a control,
or an adequate inhibitor (3 mM bafetinib, 10 nM CHIR-98014, or
a combination of both) for an hour and resuspended in PBSwith the
respective inhibitor for use in the microfluidics chip. High-speed
videos were obtained at 900 to 1500 frames per second and
converted into .tiff frame sequences with the use of Phantom
Camera Control (PCC) v2.2 or Cine Viewer (CV) v3.1 software.
High-speed video analysis
All images resulting from the high-speed videos were processed
with the use of Fiji v. 2.0.0-rc-54/1.51h.25 A detailed method for
high-speed video analysis is provided in the supplemental Methods.
Raw proteomics data and data preprocessed with Proteome
Discoverer are available via ProteomeXchange with identifiers
PXD013652 and PXD013960, with corresponding DOIs 10.6019/
PXD013652 and 10.6019/PXD013960. Proteomics data tables
from preprocessing with Proteome Discoverer may also be found in
the supplemental Data.
Filtered proteomics data from the microsphiltration and micro-
fluidics proteomics analyses may be respectively found in supple-
mental Tables 1 and 2.
Results
The RBC phosphoproteome is modulated in response
to deformation
Due to the relatively short timeframe required for the deformation
and recovery of RBCs and the general lack of transcriptional
machinery, we hypothesized that any underlying mechanism for
responding to deformation would necessarily be driven by post-
translational modification of proteins via phosphorylation. Altered
phosphorylation of cytoskeletal and membrane proteins is known
to influence multiple properties in the erythrocyte (eg, membrane
stability and tension, deformability, effective viscosity16,26-28),
principally through changes in cytoskeletal stability and in the
association between cytoskeletal proteins and the multiprotein
membrane complexes. Given the reported increased kinase activity
of reticulocytes29 and the fact that many proteins are lost during
reticulocyte maturation to the erythrocyte,30 investigating reticulo-
cyte response to deformation may allow for increased sensitivity
in the detection of deformation-induced signaling cascades. Thus,
to investigate any possible changes underlying deformation and
recovery, we produced 2 qualitative phosphoproteomics datasets
comparing erythrocytes from 3 donors and in vitro CD341-derived
cultured reticulocytes from 4 donors lysed before, during, and after
passage through the spleen-like microsphiltration system originally
developed by Deplaine et al.24 In vitro–generated reticulocytes
were used in preference to reticulocytes isolated from donors
because of the high number of cells required per complete sample
set in the microsphiltration experiment, although we have previously
shown that in vitro and in vivo reticulocytes are proteomically similar
both in quantitative protein abundance and presence of specific
phosphopeptides.23
Figure 1A summarizes the design of the experiment and includes
micrographs of erythrocytes in the 3 conditions. Cells analyzed
in the beginning of the experiment possess the characteristic
biconcave morphology, whereas a majority of the cells fixed during
passage through the microsphiltration system are in the process of
being deformed (although the degree to which they are deformed
varies for each cell). Cells that have undergone passage through
the system regain their biconcave morphology without any visible
alteration. Resulting processed proteomics data from the experi-
ment may be found in supplemental Table 1.
A significant proportion of the detected phosphopeptides were
unique to the deformed or recovery states in erythrocytes (52.4% of
detected phosphopeptides) and reticulocytes (24.3% of detected
phosphopeptides), as summarized in Figure 1B. Further analysis
of these phosphopeptide groups through use of the STRING
database revealed a predicted common underlying protein-protein
interaction network, which is shown in Figure 1C. Two main groups
of proteins were observed to be connected through this network,
namely kinases and intracellular transport proteins (as identified by
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Cytoplasmic linker associated protein 2 (CLASP2)
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Guanine nucleotide exchange factor for Rab-3A
(RAB3IL1)
Mitogen-activated protein kinase kinase kinase 7
(MAP3K7)
Peroxiredoxin-6 (PRDX6)
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F
Figure 1. Red blood cell deformation induces measurable changes in the phosphoproteome. (A) Experimental design for proteomic comparison: RBCs and cultured
reticulocytes were subjected to flow in a microsphiltration system and lysed before, during, and after passage. The lysates were equalized through hemoglobin quantification using
Drabkin’s reagent and analyzed through NanoLC-MS/MS. Cells were fixed and imaged under brightfield at all 3 stages, showing the extent of their deformation within the system and
their recovery after passage. Scale bars, 10 mm. (Microsphiltration schematic adapted from Duez et al.48) (B) Venn diagram of differentially phosphorylated proteins with $50% detection
across all samples in RBCs (left, n 5 63 with 33 modifications detected exclusively in cells mid- and postdeformation) and reticulocytes (right, n 5 226 with 55 modifications detected
exclusively in cells mid- and postdeformation). (C) Top-scoring protein-protein interaction network from the joint dataset of mid- and postdeformation exclusive phosphoproteins in retic-
ulocytes, as predicted by STRING.49 Two main subsets of proteins were present in the network, kinases (marked in red) and vesicle transport-related proteins (marked in dark blue). (D)
List of phosphoproteins exclusive to the RBC mid-deformation and mid-/postintersection datasets. Count indicates the number of observed instances of the phosphopeptide (n 5 3); the
phosphopeptides were sorted by the sum of their counts in both datasets and filtered for their presence in at least 2 samples per condition. PhosphoSite location indicates the predicted
location of the phosphorylation site in the protein sequence (as predicted by SEQUEST and/or PhosphoSitePlus data50), as well as the effect of its phosphorylation if described in low-
throughput studies according to PhosphoSitePlus.50 (E) List of phosphoproteins exclusive to the reticulocyte mid-deformation and mid-/postintersection datasets (n 5 4). Dataset analy-
sis, filtering, and annotation were performed as previously described. (F) List of phosphoproteins present among both reticulocyte and RBC mid-/postdeformation datasets, with no
significant detection in the predeformation dataset; dataset analysis, filtering, and annotation were performed as previously described.
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red and blue outlines, respectively). The only KEGG pathway
detected in the dataset through enrichment analysis was related to
AMPK signaling (KEGG enrichment performed with the use of
DAVID 6.8,31,32 P 5 .029), although no AMPK-related phospho-
peptides were detected (suggesting we are capturing downstream
phosphorylation events). Phosphopeptides detected only in eryth-
rocytes are listed in the table in Figure 1D, whereas phosphopep-
tides detected only in reticulocytes are listed in Figure 1E. As
expected, a much broader variety of novel peptides phosphorylated
during or after deformation was detected in reticulocytes compared
with erythrocytes. Although this finding may be related to the
previously mentioned higher kinase activity in reticulocytes,29 it may
also potentially highlight the existence of only a temporary role for
the detected proteins and respective phosphorylations. Interest-
ingly, only a small overlap was detected between erythrocytes and
reticulocytes (Figure 1F), which could also be related to differences
in the activation kinetics for signaling and recovery of the cell from
deformation (or, again, due to known differences in kinase
abundances between the cell types). It is noteworthy that only the
phosphopeptide corresponding to NSFL1C was consistently
detected among the 2 cell types in both the mid- and postdefor-
mation states, despite no information existing on its effect in
erythroid cells.
Inhibition of Lyn and GSK3 decreases RBC capacity to
undergo repeated deformation
Notably, phosphorylations with well-defined effects on kinase
activity were also detected by our experimental approach in
reticulocytes. Because of the ubiquitous presence of their
phosphopeptides in the reticulocyte postdeformation samples, we
focused our attention on the kinases Lyn and GSK3a. The tyrosine
kinase Lyn is a known regulator of the erythrocyte protein band 3,
a cytoskeleton-interacting protein known to be the most abundant
membrane protein in RBCs.33 Its kinase activity is partially regulated
through autophosphorylation of the tyrosine residue in site Y397,
which was detected in this dataset and has been well-described to
induce further activation of the protein.34 Conversely, serine/
threonine kinases of the GSK3 family have been shown to
participate in the phosphorylation of b-adducin,35 which is also
known to interact with the spectrin-actin cytoskeleton in eryth-
rocytes.36 Tyrosine phosphorylation of GSK3a at the Y279 site,
which we have detected in this dataset, is known to increase
enzymatic activity.37
Given that modulating the activity of both kinases could have
a quantifiable impact on the erythroid cytoskeleton, we decided to
attempt chemical inhibition and subsequent cell microsphiltration to
investigate a putative effect on the ability of reticulocytes to undergo
successive deformations. In addition to the 2 kinase inhibitors,
treatment with an anti-glycophorin A (GPA) antibody was used as
a positive control for detrimental effects on cell deformability, as
GPA ligation has been demonstrated to increase cell rigidity.38 After
treatment, the cells were mixed at approximately 5:95 ratio with
untreated erythrocytes, as per a previously published method by
Cluitmans et al,39 and allowed to settle on the surface of the
microbead layer. Even, manual pressure was applied and the
percentage of reticulocytes that traversed the system was
evaluated using flow cytometry through the detection of CellTracker
Green CMFDA-labeled cells. The results for this experiment are
shown in Figure 2A.
Predictably, pretreatment with the anti-GPA antibody significantly
affected cell traversal through microsphiltration. Inhibition of Lyn
kinase showed a nonsignificant reduction in the percentage of cells
obtained after passage through the system, whereas inhibition of
GSK3 showed a significant reduction that was comparable to
treatment with the anti-GPA antibody. Importantly, and in contrast to
cells treated with the anti-GPA antibody, treatment with either
inhibitor did not affect intrinsic capacity to undergo initial de-
formation as assayed through the Deformability Index distributions
obtained by an Automated Rheoscope and Cell Analyzer (supple-
mental Figure 1). To further investigate the effect of inhibiting these
2 kinases, we used a microfluidics-based system (previously
published by Lizarralde-Iragorri et al19) to subject the cells to shear
stress and successive deformations in an observable manner. The
chip is shown in Figure 2B, with an accompanying example of cells
passing through the system (which may also be observed in
supplemental Video 1) and being subjected to automatic tracking
(supplemental Video 2). Through use of this system, we identified
a general decrease in microcapillary traversal velocity in both
reticulocytes and erythrocytes after treatment to inhibit Lyn or
GSK3, as summarized in Figure 2C. In cases in which the
comparison P value was higher than the significance cutoff,
a decrease in cell velocity is still observed across all samples, with
a large variation between samples causing the low significance.
Concomitant treatment with both inhibitors had a compounding
effect, resulting in near-complete inability of cells to traverse the
microfluidics chip and leading to highly variable results (eg,
complete blockage of the system led to extremely slow traversal
as shown in supplemental Video 3). We thus identify for the first
time a requirement for both Lyn and GSK3 for regulating the
capacity of cells to undergo successive deformations and resist
shear stress.
Cells passing through the microfluidics system can be lysed near-
immediately after deformation (we estimate there to be a maximum
interval of 3 seconds between the last constriction point and the
end of the capillary traversal), an interval that we considered
significantly different to the approximately 5-minute period neces-
sary to obtain samples following microsphiltration. Therefore, we
combined the phosphoproteomics data from both experiments
to create a comprehensive integrative dataset (shown in Table 1,
with processed phosphoproteomics data from the microfluidics
experiment provided in supplemental Table 2), which lists the
phosphorylation sites most likely to be modulated as a result of
shear stress recognition in the reticulocyte, generating a unique and
unprecedented dataset that characterizes a highly transient state of
this dynamic cell.
Discussion
Studying the dynamic processes involved in reticulocyte maturation
or changes in the erythrocyte in response to mechanical stimulus
presents inherent challenges due to the short-lived nature of said
processes and, consequently, the technical difficulties of obtaining cells
in a physiologically relevant state of deformation/posttranslational
modification. Previous proteomic studies of the RBC and reticulo-
cyte have mostly focused mainly on deriving definitive descriptive
proteomes or studying quantitative differences in protein content
between these cell types,23,40-43 although we have also recently
published a dataset that characterizes important differential phosphor-
ylation between erythrocytes and endogenous/cultured reticulocytes.23
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However, none of these studies have investigated the possibility of
posttranslational modifications actively changing within the cell over
time as a direct consequence of the physiological stress involved in
circulation. Previous studies have indicated that signaling pathways are
at least involved in the changes induced in RBC aging,13 but the use of
pharmacological compounds to induce a response will most likely
generate outcomes that range beyond what the cell normally
experiences.
Therefore, in this study, we report the first qualitative phosphopro-
teomic dataset that dissects the response to deformation and shear
stress in the human reticulocyte and erythrocyte, identifying
previously unreported protein modifications and signaling pathways
and investigating the impact of inhibiting part of those pathways.
To achieve this, we have combined the use of 2 established
systems that mimic physiological deformation of RBCs19,24 with
high-throughput proteomics based on titanium dioxide enrichment,
allowing us to investigate the difference in phosphorylation events
present before, during and after deformation. By combining
datasets derived from systems that mimic splenic passage and
capillary deformation, we identify posttranslational modifications in
several reticulocyte membrane and cytoskeletal proteins, including
ankyrin, dematin, a/b-spectrin, and Piezo1, which we show are
associated with mechanical stimulus and hypothesize may be
modulated as part of the shear-induced reticulocyte maturation
process due to their detection in reticulocytes occurring only after
exposure to deformation.
Focusing on the signaling pathways that seemingly activate upon
reticulocyte deformation, we used pharmacological kinase inhibitors
to inhibit Lyn and GSK3, 2 kinases with a predicted impact on the
erythroid cytoskeleton, and thus identified an effect of those kinases
on the cell’s capacity to undergo successive deformations.
Together with Syk, the tyrosine kinase Lyn has been reported to
phosphorylate the erythrocyte membrane protein band 3,33 leading
to changes in red cell properties, including membrane stability and
intracellular pH.44 Altered Lyn kinase activity resulting in band 3
hyperphosphorylation and disruption in erythrocyte membrane-
cytoskeletal connectivity and compromised RBC stability is among
the defining features of the disease chorea-acanthocytosis.45 The
regulation of Lyn activity occurs partially through autophosphor-
ylation of the tyrosine residue in site Y397, which we have detected
in this dataset and is well-described to induce further activation of
the protein.34 Interestingly, no phosphorylated tyrosine residues of
band 3 were found to be exclusive to mid- or postdeformation
samples, although the residue targeted by Lyn kinase (tyrosine 359)
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Figure 2. GSK3 and Lyn inhibition impacts capillary traversal of reticulocytes and red blood cells. (A) Percentage recovery of reticulocytes treated with the
respective reagent after microsphiltration. After treatment, the cells were added to an untreated RBC suspension in a 5:95 ratio and the mixture then subjected to
microsphiltration. Anti-GPA antibody was used as a positive control for negative effects on cell deformability. Bafetinib (3 mM) was used as a Lyn inhibitor and CHIR-98014
(10 nM) was used as a GSK3 inhibitor. Error bars correspond to the standard deviation (n 5 3). All comparisons were performed with a paired 2-tailed Student t test. The P
values for each comparison are shown below the bar graph. *P , .05, **P , 0.01. (B) Image of the microfluidic PDMS biochip used for the capillary traversal experiment. The
magnified image shows a section of the microcapillary channels, through which reticulocytes and red blood cells were subjected to successive deformations. Frame sequences
were obtained through the use of a high-speed camera and then subjected to image analysis for automated cell tracking with the use of TrackMate.51 Scale bars, 50 mm.
(C) Percentage microcapillary traversal velocity of reticulocytes and red blood cells treated with the respective reagents. The cells were treated for a minimum period of 1 hour
and subjected to passage through the microfluidic biochip. The graph shows the average cell microcapillary traversal velocity of each treated sample as a percentage of
the respective DMSO control sample traversal velocity. All comparisons were performed with a 1-sample Student t test. The error bars correspond to the standard devia-
tion (n 5 3). The P values for each comparison are shown below the dot plot. *P , .05, **P , .01. A minimum of 1000 cell tracks were analyzed per sample. n.s.s., not
statistically significant.
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Table 1. Integrative list of deformation-induced phosphorylations in the reticulocyte
Accession no.
Gene
symbol Protein name Sequence Count Site
E9PIJ1 AMPD2 AMP deaminase 2 TDSDSDLQLYK 7* S190/S197
A0A0U1RQT1 ACAP2 Arf-GAP with coiled-coil, ANK repeat, and PH
domain-containing protein 2
SSPSTGSLDSGNESK 7* S384
B7Z3I9 ALAD D-aminolevulinic acid dehydratase SSPAFGDR 7 S215
P49840 GSK3A Glycogen synthase kinase-3 a GEPNVSYICSR 7* Y279
P49840 GSK3A Glycogen synthase kinase-3 a TSSFAEPGGGGGGGGGGPGGSASGPGGTGGGK 7* S21/S39
E9PK89 RAB3IL1 Guanine nucleotide exchange factor for Rab-3A TLVITSTPASPNR 7 S168
B4DMA2 HSP90AB1 Heat shock protein HSP 90-b IEDVGSDEEDDSGKDK 7* S255
Q9H1E3 NUCKS1 Nuclear ubiquitous casein and cyclin-dependent kinase
substrate 1
VVDYSQFQESDDADEDYGR 7* S19
S4R2Y4 CBX3 Chromobox protein homolog 3 SLSDSESDDSK 6 S93
Q08495 DMTN Dematin DSSVPGSPSSIVAK 6 S26
Q9UG54 MAP3K7 Mitogen-activated protein kinase kinase kinase 7 SIQDLTVTGTEPGQVSSR 6 S439
P61006 RAB8A Ras-related protein Rab-8A KLEGNSPQGSNQGVK 6 S181/S185
B3KVN0 SLC2A1 Solute carrier family 2, facilitated glucose transporter member 1 TPEELFHPLGADSQV 6 S490
A0A087WYB4 STOML2 Stomatin-like protein 2, mitochondrial APVPGTPDSLSSGSSR 6 T327
Q8IV54 TSC22D4 TSC22D4 protein NGSPPPGAPSSR 6 S62
P16157 ANK1 Ankyrin-1 NGASPNEVSSDGTTPLAIAK 5 S759
A0A0U1RQT1 ACAP2 Arf-GAP with coiled-coil, ANK repeat, and PH
domain-containing protein 2
YSISLSPPEQQK 5 S521
P27824 CANX Calnexin QKSDAEEDGGTVSQEEEDR 5 S564
G3V238 EEF1AKMT2 EEF1A lysine methyltransferase 2 SDKGSPGEDGFVPSALGTR 5 S21
P05198 EIF2S1 Eukaryotic translation initiation factor 2 subunit 1 VVTDTDETELAR 5 T279
F8WAE5 EIF2A Eukaryotic translation initiation factor 2A SDKSPDLAPTPAPQSTPR 5 S506
C9JII4 GCFC2 GC-rich sequence DNA-binding factor 2 ELPVPGSAEEEPPSGGGR 5 S40
Q2VPJ6 HSP90AA1 HSP90AA1 protein DKEVSDDEAEEK 5 S231
D3DWY2 IKBKG Inhibitor of k light polypeptide gene enhancer in B-cells,
kinase g
SPPEEPPDFCCPK 5 S387
O60307 MAST3 Microtubule-associated serine/threonine-protein kinase 3 SSENVLDEEGGR 5 S134
F2Z2K0 NSFL1C NSFL1 cofactor p47 SPNELVDDLFK 5 S114
B7Z8Y1 NFATC2 Nuclear factor of activated T-cells, cytoplasmic 2 TSPDPSPVSAAPSK 5 S330
H0Y5Q9 INPP5D Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 GESPPTPPGQPPISPK 5 T963
D6RC77 PGM3 Phosphoacetylglucosamine mutase STIGVMVTASHNPEEDNGVK 5 S64
M4QHP2 PIEZO1 Piezo-type mechanosensitive ion channel component SGSEEAVTDPGER 5 S1621
Q9BVG4 PBDC1 Protein PBDC1 GADSGEEKEEGINR 5 S197
B4E3V2 SQSTM1 Sequestosome-1 LTPVSPESSSTEEK 5 T269/S272
Q6PJD5 SHARPIN SHARPIN protein SPGNLTER 5 S165
B2RMN7 SPTB Spectrin b chain TSPVSLWSR 5 S2114/S2117
C9JWF0 SMC4 Structural maintenance of chromosomes protein 4 REEGPPPPSPDGASSDAEPEPPSGR 5 S22
H0YN01 TLN2 Talin-2 LDEGTPPEPK 5 T1843
C9J3F6 TBC1D5 TBC1 domain family member 5 NISSSPSVESLPGGR 5 S541/S544
E9PJJ0 TBCEL Tubulin-specific chaperone cofactor E-like protein YSPENFPYR 5 S18
Q8IXQ3 C9orf40 Uncharacterized protein C9orf40 RDSGDNSAPSGQER 5 S76
Q5JSH3 WDR44 WD repeat-containing protein 44 VGNESPVQELK 5 S50
F8WBS8 PSMD2 26S proteasome non-ATPase regulatory subunit 2 DKAPVQPQQSPAAAPGGTDEKPSGK 4 S16
Q92625 ANKS1A Ankyrin repeat and SAM domain-containing protein 1A SESLSNCSIGK 4 S647
List of significantly enriched or exclusive phosphopeptides in reticulocytes after deformation, as assayed through microsphiltration and microcapillary traversal. Generally, only
phosphopeptides present in at least 4 of the 7 postdeformation samples (4 microsphiltration1 3 microfluidics) and not present in at least 4 of the 7 predeformation samples were included. The
exception to this analysis consists of the phosphopeptides counted as 7*, which were present in all postdeformation samples but also in 4 of 7 of the predeformation samples. The prediction of the
most probable phosphosites in the phosphopeptide was included according to the count of occurrences in previous low-throughput and high-throughput studies, as assayed through
PhosphoSitePlus.50
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was observed to be phosphorylated across all samples. It is
important to note that our experimental analysis is focused on the
identification of phosphopeptides which are uniquely associated
with deformation. Therefore, basally phosphorylated proteins for
which deformation-induced changes constitute an alteration in
abundance of the phosphorylated population would not be included
in our list. This approach will undoubtedly result in a smaller list of
candidate deformation-associated modifications relative to that
which could be achieved using comparative quantitative alternatives
(such as TMT labeling). Nevertheless, it both enables a greater input
of material to be used (increasing the likelihood of detecting
phosphopeptides that are only present in low abundance) and,
crucially, generates targets that are easier to modulate experimen-
tally because no quantity-based effects need to be accounted for
Table 1. (continued)
Accession no.
Gene
symbol Protein name Sequence Count Site
E9PJP4 EPB41L2 Band 4.1-like protein 2 EVAENQQNQSSDPEEEKGSQPPPAAESQSSLR 4 S39/S58
A8MZ77 BSG Basigin RKPEDVLDDDDAGSAPLK 4 S362
Q9NSY1 BMP2K BMP-2-inducible protein kinase DSQSSNEFLTISDSK 4 S1029
A0A0C4DGD1 CAST Calpastatin DTSQSDKDLDDALDK 4 S563
Q9Y5K6 CD2AP CD2-associated protein KNSLDELR 4 S582
Q8TEH3 DENND1A DENN domain-containing protein 1A TGGTLSDPEVQR 4 T24
B4DU91 EPN1 Epsin-1 SPGAFDMSGVR 4 S435
M0QXW7 KHSRP Far upstream element-binding protein 2 VQISPDSGGLPER 4 S181
F5H1C6 FERMT3 Fermitin family homolog 3 TASGDYIDSSWELR 4 Y11
P04075 ALDOA Fructose-bisphosphate aldolase A GILAADESTGSIAKR 4 S36
H0YJ30 GPHN Gephyrin ASHSAVDITK 4 S303/S305
Q2Q9B7 G6PD Glucose-6-phosphate 1-dehydrogenase VQPNEAVYTK 4 Y401
E9PK89 RAB3IL1 Guanine nucleotide exchange factor for Rab-3A ELHPQLLSPTK 4 S179
O75633 GNAS Guanine nucleotide-binding protein Gs a subunit isoform L3 ISTASGDGR 4 S352
Q5H924 HUWE1 HECT, UBA, and WWE domain containing 1 REESPMDVDQPSPSAQDTQSIASDGTPQGEK 4 S3816
A0A0F7NGI8 LRRFIP1 Leucine rich repeat IDGATQSSPAEPK 4 S714
E9PJF4 CLNS1A Methylosome subunit pICln EPVADEEEEDSDDDVEPITEFR 4 S102
S4R3D6 APIP Methylthioribulose-1-phosphate dehydratase DISGPSPSKK 4 S87
Q6NT16 SLC18B1 MFS-type transporter SLC18B1 SKSQNILSTEEER 4 S438
B4DS42 OATL1 Ornithine aminotransferase-like 1 QASLDGLQQLR 4 S506
P30041 PRDX6 Peroxiredoxin-6 DFTPVCTTELGR 4 T44
I3L1U0 RILP Rab-interacting lysosomal protein AESSEDETSSPAPSK 4 S354
Q9P227 ARHGAP23 r GTPase-activating protein 23 SAEALGPGALVSPR 4 S361/S372
Q16513 PKN2 Serine/threonine-protein kinase N2 ASSLGEIDESSELR 4 S583
C9JIG9 OXSR1 Serine/threonine-protein kinase OSR1 TEDGGWEWSDDEFDEESEEGK 4 S339
P02549 SPTA1 Spectrin a chain, erythrocytic 1 QDTLDASLQSFQQER 4 S1976
B2RMN7 SPTB Spectrin b chain LSSSWESLQPEPSHPY 4 S2123/S2125/S2128
B4DZC9 SLK STE20-like serine/threonine-protein kinase VDEDSAEDTQSNDGK 4 S571
P17987 TCP1 T-complex protein 1 subunit a HGSYEDAVHSGALND 4 S544/Y545
B4DUI5 TPI1 Triosephosphate isomerase IIYGGSVTGATCK 4 Y246
Q8IV54 TSC22D4 TSC22D4 protein VEAEAGGSGARTPPLSR 4 T229
B4DQ79 LYN Tyrosine-protein kinase VIEDNEYTAR 4 Y397
A0A024R8I2 UBADC1 Ubiquitin associated domain containing 1, isoform CRA_c APSPLPK 4 S98
Q5VVQ6 YOD1 Ubiquitin thioesterase OTU1 SSPAFTK 4 S130
B3KW31 VPS13A Vacuolar protein sorting 13A QASFTDVRDPSLK 4 S1416
A0A0S2Z3K9 CRK V-crk sarcoma virus CT10 oncogene-like protein isoform 2 DSSTSPGDYVLSVSENSR 4 S41
List of significantly enriched or exclusive phosphopeptides in reticulocytes after deformation, as assayed through microsphiltration and microcapillary traversal. Generally, only
phosphopeptides present in at least 4 of the 7 postdeformation samples (4 microsphiltration 1 3 microfluidics) and not present in at least 4 of the 7 predeformation samples were included.
The exception to this analysis consists of the phosphopeptides counted as 7*, which were present in all postdeformation samples but also in 4 of 7 of the predeformation samples. The
prediction of the most probable phosphosites in the phosphopeptide was included according to the count of occurrences in previous low-throughput and high-throughput studies, as
assayed through PhosphoSitePlus.50
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when interfering with protein activity (given that these modifications
are not present in the nondeformed cell and thus are not essential
for their survival, at least in vitro).
In contrast to Lyn, the impact of GSK3a in RBCs is markedly
less well-characterized. GSK3 is a serine/threonine kinase which
has been shown to phosphorylate multiple sites in b-adducin and
consequently regulate its activity in cortical neurons.35 In eryth-
rocytes, b-adducin interacts with band 3 and with the spectrin-
actin cytoskeleton, stabilizing the junctional complex and regulating
membrane deformability.36 No phosphorylated residue of b-adducin
was detected in our datasets to be exclusive to cells undergoing or
recovering from deformation; however, given the presence of the
GSK3-phosphorylated b-adducin peptide in the predeformation
samples and the previously described limitations, it is tantalizing to
speculate that modification of this site could be involved in the
regulation of membrane-cytoskeletal connectivity of RBCs.
Interestingly, a compounding effect was repeatedly observed when
inhibiting the 2 kinases, suggesting the existence of independent
mechanisms that are activated by the same initial stimulus.
However, neither inhibitor affected the inherent capacity of the
cells to undergo deformation (as assessed by rheoscopy) in
contrast to treatment with an anti-GPA antibody. Although we
cannot exclude that varying shear stress levels or exposure times
induced by the different modalities may contribute to this result, we
hypothesize that inhibiting these mechanisms results in an inability
to recover from successive deformations rather than an inability to
deform. The initial deformability of the cell could, therefore, be
primarily related to its inherent biophysical properties46 and not
necessarily to a signaling pathway response (especially given the
very short timeframe required for deformation). Nonetheless, as
showcased by our functional assay studies, kinase activity and thus
phosphorylation is clearly an important event in the regulation of
physiological deformation.
In conclusion, our results not only present previously undescribed
mechanisms for shear stress and deformation response in human
erythrocytes and reticulocytes, but also serve as a valuable resource for
further mechanistic dissection of the molecular pathways that underlie
the RBC’s response to mechanical stimuli and for the study of
reticulocyte maturation.
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